Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are probably the most maturely produced TPD techniques. In this particular evaluate, we target both preclinical experiments and medical trials to provide an extensive summary of the safety and medical effectiveness of PROTACs and MGDs in hematologic malignancies over the past 20 https://christm418chm2.wikibuysell.com/user